<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>About FAIL MAP - Trialsage.ai</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="/static/styles.css">
</head>
<body class="bg-gray-50">
    <div class="container mx-auto p-6">
        <nav class="flex justify-between items-center mb-8">
            <a href="/" class="text-4xl font-bold text-blue-800">
                Trialsage<span class="text-blue-600">.ai</span>
            </a>
            <div class="flex space-x-4">
                <a href="/" class="px-4 py-2 bg-gray-200 hover:bg-gray-300 rounded-lg transition-colors">
                    Home
                </a>
                <a href="/about" class="px-4 py-2 bg-blue-600 text-white hover:bg-blue-700 rounded-lg transition-colors">
                    About
                </a>
            </div>
        </nav>

        <div class="max-w-4xl mx-auto">
            <div class="bg-white rounded-xl shadow-lg p-8 mb-12">
                <h1 class="text-4xl font-bold mb-6 text-blue-800">About FAIL MAP</h1>
                
                <div class="prose max-w-none text-gray-700">
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">What is FAIL MAP?</h2>
                    <p class="mb-4">
                        FAIL MAP (Failure Analysis and Intelligent Learning for Medical Advancement Protocol) is an AI-powered 
                        platform developed by Trialsage.ai for predicting and analyzing clinical trial failure risks. Our system leverages 
                        advanced machine learning techniques to provide data-driven insights for clinical trial protocol optimization.
                    </p>
                    
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">Our Data</h2>
                    <p class="mb-4">
                        The FAIL MAP platform is powered by a comprehensive database of 3,000 simulated clinical studies, carefully 
                        modeled to reflect real-world success and failure patterns across various therapeutic areas. Our data model 
                        incorporates a wide range of parameters that influence trial outcomes, including:
                    </p>
                    
                    <ul class="list-disc pl-8 mb-4 space-y-2">
                        <li>Therapeutic areas and specific indications</li>
                        <li>Trial phase and design (randomization, blinding)</li>
                        <li>Study population characteristics</li>
                        <li>Sample size considerations</li>
                        <li>Endpoint selection and measurement</li>
                        <li>Regional and geographic factors</li>
                    </ul>
                    
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">How It Works</h2>
                    <p class="mb-4">
                        FAIL MAP uses a sophisticated combination of machine learning algorithms to analyze clinical trial protocols:
                    </p>
                    
                    <ol class="list-decimal pl-8 mb-4 space-y-2">
                        <li>
                            <strong>Natural Language Processing:</strong> Extracts key features from protocol text such as therapeutic area, 
                            phase, sample size, randomization approach, blinding methodology, and primary endpoints.
                        </li>
                        <li>
                            <strong>Similarity Matching:</strong> Identifies historical studies with similar characteristics to provide 
                            context and relevant comparisons.
                        </li>
                        <li>
                            <strong>Predictive Modeling:</strong> Employs Random Forest classification to predict success probability 
                            based on multiple protocol features and their interactions.
                        </li>
                        <li>
                            <strong>Risk Analysis:</strong> Identifies specific elements of the protocol that contribute to increased 
                            failure risk based on patterns observed in similar studies.
                        </li>
                        <li>
                            <strong>Recommendation Engine:</strong> Generates targeted recommendations for protocol optimization to 
                            increase success probability.
                        </li>
                    </ol>
                    
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">Technology Stack</h2>
                    <p class="mb-4">
                        FAIL MAP is built using a modern technology stack designed for performance, scalability, and reliability:
                    </p>
                    
                    <ul class="list-disc pl-8 mb-4 space-y-2">
                        <li><strong>Backend:</strong> Python, Flask, SQLite</li>
                        <li><strong>Machine Learning:</strong> scikit-learn, NumPy, Pandas</li>
                        <li><strong>Data Visualization:</strong> Plotly, Matplotlib</li>
                        <li><strong>Frontend:</strong> HTML, CSS, JavaScript, Tailwind CSS</li>
                        <li><strong>Natural Language Processing:</strong> Regular expressions, pattern matching</li>
                    </ul>
                    
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">Use Cases</h2>
                    <p class="mb-4">
                        FAIL MAP is designed to support a wide range of stakeholders in the clinical trial ecosystem:
                    </p>
                    
                    <ul class="list-disc pl-8 mb-4 space-y-2">
                        <li>
                            <strong>Pharmaceutical and Biotech Companies:</strong> Optimize protocol design prior to submission, 
                            reducing the risk of costly trial failures.
                        </li>
                        <li>
                            <strong>Academic Researchers:</strong> Improve study design to maximize successful outcomes with 
                            limited funding and resources.
                        </li>
                        <li>
                            <strong>Contract Research Organizations (CROs):</strong> Provide data-driven guidance to sponsors 
                            on protocol optimization.
                        </li>
                        <li>
                            <strong>Regulatory Consultants:</strong> Identify potential design weaknesses prior to regulatory 
                            submission and review.
                        </li>
                    </ul>
                    
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">Limitations</h2>
                    <p class="mb-4">
                        While FAIL MAP provides valuable insights, users should be aware of the following limitations:
                    </p>
                    
                    <ul class="list-disc pl-8 mb-4 space-y-2">
                        <li>
                            FAIL MAP is based on simulated clinical trial data, designed to reflect general patterns 
                            and relationships observed in real-world studies.
                        </li>
                        <li>
                            Predictions and recommendations should be considered as advisory and should not replace expert 
                            medical or regulatory guidance.
                        </li>
                        <li>
                            The success probability estimates are relative indicators rather than absolute probabilities of 
                            regulatory approval.
                        </li>
                        <li>
                            Special considerations for novel therapeutic approaches or unique patient populations may not be 
                            fully captured by the current model.
                        </li>
                    </ul>
                    
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">Future Development</h2>
                    <p class="mb-4">
                        The Trialsage.ai team is continuously working to enhance FAIL MAP with new features and capabilities:
                    </p>
                    
                    <ul class="list-disc pl-8 mb-4 space-y-2">
                        <li>Integration with real-world clinical trial databases for enhanced prediction accuracy</li>
                        <li>Advanced therapeutic area-specific models for specialized domains</li>
                        <li>PDF protocol document extraction and automated analysis</li>
                        <li>Regulatory submission pre-check capabilities</li>
                        <li>Expanded visualization and reporting features</li>
                    </ul>
                    
                    <h2 class="text-2xl font-bold mt-8 mb-4 text-blue-700">Contact Us</h2>
                    <p class="mb-4">
                        For more information about FAIL MAP or to provide feedback, please contact the Trialsage.ai team at:
                    </p>
                    
                    <p class="mb-4">
                        Email: <a href="mailto:info@trialsage.ai" class="text-blue-600 hover:underline">info@trialsage.ai</a><br>
                        Website: <a href="https://trialsage.ai" class="text-blue-600 hover:underline" target="_blank">https://trialsage.ai</a>
                    </p>
                </div>
            </div>
            
            <footer class="text-center text-gray-500 text-sm mt-20">
                <p>Â© 2025 Trialsage.ai - Global Intelligence System for Clinical Study Reports</p>
                <p class="mt-1">Analysis based on 3,000 clinical studies with advanced AI interpretation</p>
            </footer>
        </div>
    </div>
</body>
</html>